Protein kinase A (PRKACA) has been documented as a pivotal regulator in meiosis and mitosis arrest. Although our previous work has established that PRKACA regulates cell cycle progression of mouse fertilized eggs by inhibiting M-phase promoting factor (MPF), little is known about the intermediate factor between PRKACA and MPF in the mitotic cell cycle. In this study, we investigated the role of the PRKACA/CDC25B pathway on the early development of mouse fertilized eggs. Overexpression of unphosphorylatable CDC25B mutant (Cdc25b-S321A or Cdc25b-S229A/S321A) rapidly caused G 2 -phase eggs to enter mitosis. Microinjection of either Cdc25b-WT or Cdc25b-S229A mRNA also promoted G 2 /M transition, but much less efficiently than Cdc25b-S321A and Cdc25b-S229A/S321A. Moreover, mouse fertilized eggs overrode the G 2 arrest by microinjection of either Cdc25b-S321A or Cdc25b-S229A/S321A mRNA, which efficiently resulted in MPF activation by directly dephosphorylating CDC2A-Tyr15, despite culture under conditions that maintained exogenous dibutyryl cAMP. Using a highly specific antibody against phospho-Ser321 of CDC25B in Western blotting, we showed that CDC25B-Ser321 was phosphorylated at the G 1 and S phases, whereas Ser321 was dephosphorylated at the G 2 and M phases in vivo. Our findings identify CDC25B as a potential target of PRKACA and show that PRKACA regulates G 2 /M transition by phosphorylating CDC25B-Ser321 but not CDC25B-Ser229 on the first mitotic division of mouse fertilized eggs.
INTRODUCTION
M-phase promoting factor (MPF), a master regulator in the mammalian cell cycle of mitosis and meiosis, is composed of an enzymatic subunit, CDC2A, and an activating subunit, CCNB1. During interphase, CDC2A is inactive via inhibitory phosphorylation on tyrosine 15 (Tyr15) and threonine 14 (Thr14) by WEE1 and MYT1 [1] [2] [3] [4] , whereas it is activated by the dual-specificity phosphatase CDC25 directly at the G 2 /M transition by dephosphorylating Tyr15 and Thr14 of CDC2A, thus promoting cell cycle progression [5, 6] . In mammalian cells, the CDC25 phosphatase family, including CDC25A, CDC25B, and CDC25C, have been identified and found to regulate the cell cycle [7, 8] . Microinjection of anti-CDC25A antibodies causes a block at G 1 /S transition, suggesting a role for CDC25A in the regulation of S phase entry [9] . At G 2 /M transition, CDC25B activates the mitotic kinase CCNB1/ CDC2A in the cytoplasm and initiates mitosis [10] . Mammalian CDC25C is inactive during most of the cell cycle but is phosphorylated and activated by microinjection of purified active CDC2A at the G 2 /M transition, and only the phosphorylated form of CDC25C makes cells at G 2 phase enter M phase prematurely [11] . Although all three CDC25 family members are associated with mitosis and meiosis, CDC25B is more potent in activating MPF than CDC25A and CDC25C. Microinjection of wild-type Cdc25b mRNA into Cdc25b À/À oocytes causes activation of MPF and resumption of meiosis [12] . In HeLa cells, overexpression of CDC25B induces premature mitosis more efficiently than overexpression of CDC25C [13] .
Protein kinase A (PRKACA, previously known as PKA), a cAMP-dependent serine/threonine kinase that is composed of two regulatory subunits and two catalytic subunits, is a pivotal enzyme in the regulation of cell growth, proliferation, and cell cycle. Knockdown of RIa of PRKACA stimulates mouse oocytes to resume meiosis but results in abnormal meiotic spindle and cleavage planes [14] . More recently, it has been suggested that inactivation of PRKACA induces rat oocytes to resume meiosis through increasing the activity of MPF [15] . These results support the concept that PRKACA is responsible for maintaining meiotic arrest in mammalian oocytes. Indeed, it has been reported that in mouse [16] , Xenopus [17] [18] [19] [20] , and starfish [21] , oocyte maturation arrest is induced by the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine, purified PRKACA catalytic subunit, and PRKACA activators like cAMP and 8-Br-cAMP. However, the G 2 arrest can be reversed and induce G 2 /M transition by PKI, a heat-stable inhibitor of PRKACA, in Xenopus oocytes [22] . Recently, Han et al. [23] have shown that PRKACA can phosphorylate and activate mouse oocyte WEE2 (previously known as WEE1B), which is a key MPF inhibitory kinase, suggesting that WEE2 is the downstream substrate of PRKACA. In Xenopus oocytes, CDC25 is phosphorylated on Ser287 by PRKACA, whereas inhibition of PRKACA by PKI induces dephosphorylation of Ser287, indicating that CDC25 functions downstream of PRKACA [24] . Although it is clear that WEE2 and CDC25 are the physiologically relevant targets of PRKACA, little is known about other substrates of PRKACA in mouse oocytes and fertilized eggs.
In the present study, CDC25B has been predicted as a potential PRKACA substrate by Scansite software, which can predict the sites of phosphorylation by protein kinase. Whether CDC25B is the direct downstream substrate of PRKACA in mouse fertilized eggs has not been fully understood. Here, we characterize the elements in the PRKACA/CDC25B pathway where PRKACA acts to inhibit the mitosis of mouse one-cell embryos. We also show that CDC25B is required for the onset of mitosis in mouse fertilized eggs. Our findings identify CDC25B as a potential target of PRKACA and provide new insight into the effect of PRKACA in the regulation of early development of mouse fertilized eggs.
MATERIALS AND METHODS

Animals and Reagents
Kunming strain mice were obtained from the Department of Laboratory Animals, China Medical University (CMU). All experiments were performed at CMU in accordance with the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals. The protocol for animal handling and the treatment procedures were reviewed and approved by the CMU Animal Care and Use Committee. Unless otherwise specified, reagents were from Sigma.
Collection and Culture of Mouse Embryos
One-cell-stage mouse embryos were collected and cultured according to the method described by Hogan and Constantini [25] . Female mice at 3-4 wk old were abdominally injected with 10 IU eCG and then with 10 IU hCG 48 h later. A virgin female mouse raised on standard laboratory food was mated with a single male overnight. One-cell embryos were collected with M2 medium the next day (20 h after the hCG injection) from the oviduct of females possessing a vaginal plug. The embryos were incubated in M16 medium under equilibrated mineral oil at 378C, 5% CO 2 in air after injection with various mRNA.
Plasmid Construction and Site-Directed Mutagenesis
The cDNA of mouse CDC25B is a kind gift from Dr. Tony Hunter (The Salk Institute). The pBluescript II/SK-CDC25B-S321A (pBSK-CDC25B-S321A) was prepared by mutating Ser321 to alanine of CDC25B using the Site-Directed Mutagenesis Kit (Stratagene). The pBSK-CDC25B-S229A was prepared by mutating Ser229 to alanine of CDC25B. The primers used were 5 0 -CAG AGG CCC AGC GCA GCC CCT GAC TTG ATG TGT C-3 0 and 5 0 -GAC ACA TCA AGT CAG GGG CTG CGC TGG GCC TCT G-3 0 . The pBSK-CDC25B-S229A/S321A mutation construct was obtained by using pBSK-CDC25B-S321A as a template. All of the above recombinant plasmids were sequenced to verify the correct gene insertion and successful mutation and were used as templates for in vitro transcription.
In Vitro Transcription
All the constructs in pBluescript II/SK were cut singly with XbaI and transcribed in vitro into 5 0 -capped mRNA for microinjection using the mMESSAGE mMACHINE kit (Ambion). The in vitro-synthesized mRNA was dissolved in nuclease-free 5 mM Tris and 0.5 mM EDTA (TE; pH 7.4). We determined mRNA yield by measuring absorbance at 260 nm and carrying out modified nondenaturing gels loaded with RNA.
Microinjection and Morphology Analysis
Various Cdc25b mRNA were microinjected into the cytoplasm of one-cell embryos at S or G 2 phase using a micropipette and Eppendorf TransferMan manipulators mounted on an Olympus IX-70 inverted microscope with DIC optics. Eggs were placed in a drop of M2 medium under mineral oil in the lid of a 3-cm Falcon culture dish. Typical injection volume was 5% of total cell volume or 10 pl per egg. Messenger RNA was diluted to various concentrations in TE buffer (pH 7.4) without nuclease contaminant. Eggs in control groups were either not microinjected or were microinjected with TE buffer. Mitotic stages (G 1 , S, G 2 , and M phases) were defined as previously described [26] . The mouse fertilized eggs were classified as either having entered two-cell stage or as remaining one-cell embryos. The rate of cleavage, namely, the number of two-cell embryos resulting from one-cell embryo division, was counted from three independent experiments under a phase-contrast microscope 31 or 34 h after the hCG injection in the absence or presence of dibutyryl cAMP (dbcAMP) in control and mRNA microinjection groups.
Assay of MPF Activity
MPF kinase activity was measured using the histone H1 kinase assay [27] . Five fertilized eggs cultured in M16 medium were collected, washed in collection buffer (PBS containing 1 mg/ml polyvinyl alcohol, 5 mM EDTA, 10 mM Na 3 VO 4 , and 10 mM NaF), and then transferred to an Eppendorf tube containing 5 ll collection buffer. The Eppendorf tube was immediately stored at À708C until the kinase assay was performed.
The frozen eggs were thawed and subjected to freezing and thawing three times. A total of 25 32 P]ATP (Beijing FuRui Biotechnology) incubated at 308C for 10 min. Then, 25-ll aliquots were spotted on Whatman p81 paper, and the reaction was stopped with 5% H 3 PO 4 solution. After thorough washing, the radioactivity on the filter paper was counted with a Beckman scintillation counter.
A parallel incubation was performed to confirm the phosphorylation of histone H1. Protein extract from five eggs was incubated with 50 ll MPF buffer containing 50 lCi/ml [c- 32 P]ATP at 378C for 30 min, and the reaction was stopped by adding an equal amount of 23 SDS buffer. The reaction was then resolved on a 12% SDS-PAGE gel, and the incorporation of 32 P into histone H1 was visualized by autoradiography.
Western Blotting
Protein extracts of mouse fertilized eggs were prepared by adding approximately 200 or 300 eggs in a minimal volume of collection medium to 20 ll protein extraction buffer (100 mM NaCl, 20 mM Tris-HCL [pH 7.5], 0.5% Triton X-100, and 0.5% Nonidet P-40) containing 1 mM phenylmethylsulfonyl fluoride and 1 lg/ml leupeptin and pepstatin. Laemmli sample buffer was added to the protein extracts, and the mixture was boiled for 5 min and resolved on a 10% SDS-PAGE gel. For immunoblotting, the fractionated proteins were transferred to a nitrocellulose membrane. The membrane was blocked with 3% BSA in Tris-buffered saline containing 0.05% Tween 20 and probed with primary antibody against pTyr15 of CDC2A (1:500), phospho-CDC25B-Ser321 (1:200), CDC25B (1:200), or ACTB (1:400; Santa Cruz Biotechnology) overnight at 48C. The membrane was then incubated with a horseradish peroxidase-conjugated anti-mouse, anti-rabbit, or anti-goat secondary antibody at 1:3000 (Beijing Zhongshan Biotechnology). The proteins were detected using an enhanced chemiluminescence detection system (Piece Biotechnology).
Phospho-CDC25B-Ser321 antibody was raised in New Zealand White Rabbits against the keyhole limpet hemocyanin-conjugated phosphopeptide CQRLFRSPpSMPCS (Ptglab; Proteintech).
Statistical Analysis
All experiments were performed independently at least three times. Student t-test or one-way analysis of variance was used to evaluate the differences between multiple experimental groups using SSPS 13.0 software, and the differences were considered statistically significant at P , 0.05.
RESULTS
Overexpression of CDC25B Constructs Promotes the Mitotic Entry in Mouse Fertilized Eggs
To determine whether CDC25B is involved in the mitotic cell cycle of mouse fertilized eggs, two potential PRKACA phosphorylation sites, Ser229 and Ser321, have been predicted on CDC25B by Scansite software (http://scansite.mit.edu). Scansite programs are kinase-specific prediction programs that make predictions about whether a candidate site is a phosphorylation site of a certain kinase or of a certain group of kinases [28] . We then created a series of CDC25B mutants in which alanine was substituted for serine residue at positions 229 (S229A) and 321 (S321A) individually or in combination, and we assessed their effects on the early development of 992 mouse fertilized eggs. We therefore microinjected 0.03 ng mRNA encoding Cdc25b-S229A/S321A, Cdc25b-S321A, Cdc25b-S229A, or Cdc25b-WT into mouse fertilized eggs at S phase (22 h after the hCG injection), and microinjected eggs were incubated in M16 medium for 4 h at 378C. Mouse fertilized eggs were either not microinjected or were microinjected with TE buffer as control groups. As shown in Figure  1A , CDC25B protein accumulated at high levels in Cdc25b-S229A/S321A, Cdc25b-S321A, Cdc25b-S229A, and Cdc25b-WT mRNA-injected eggs. These results indicate that the exogenous mRNA of all kinds of CDC25B could be translated efficiently in mouse fertilized eggs. The morphology change and cleavage rate in each group were calculated after counting and were observed under a phase-contrast microscope 26-31 h after the injection of hCG (Fig. 1, B and C) . In the control groups, embryos remained at the one-cell stage 27.5 h after the hCG injection (G 2 phase; Fig. 1B, a and b) , but only 61% of embryos reached the two-cell stage 3.5 h later (31 h after the injection of hCG; Fig. 1B, c and d) , and there was no significant difference between the two control groups (P . 0.05). Embryos microinjected with Cdc25b-S321A mRNA entered M phase 26.5-27 h after the hCG injection, and the cleavage rate was up to 91% 31 h after the hCG injection (P , 0.01 vs. control groups; Fig. 1Be) . A similar pattern was seen in the Cdc25b-S229A/S321A mRNA-injected eggs (P , 0.01 vs. control groups; Fig. 1Bf ). In contrast, embryos microinjected with mRNA of either Cdc25b-S229A or Cdc25b-WT entered M phase 27.5-28 h after the hCG injection (Fig. 1B, g  and h) , and only 75.0% and 75.5% of embryos reached the two-cell stage 31 h after the hCG injection, respectively (P , 0.01 vs. Cdc25b-S321A or Cdc25b-S229A/S321A group; P , 0.05 vs. control groups). However, in all of the Cdc25b mRNA-injected groups, significantly more embryos overexpressing either CDC25B-S321A or CDC25B-S229A/S321A displayed irregular division than CDC25B-S229A and CDC25B-WT groups (Fig. 1B, i and j) . These results clearly indicate that the effect of triggering mitotic entry by either CDC25B-S321A or CDC25B-S229A/S321A is more effective, although the other CDC25Bs also result in an earlier onset of mitosis compared with the control groups in mouse one-cell stage embryos.
Cdc25b mRNA Microinjection Regulates MPF Activity and CDC2A-Tyr15 Phosphorylation
In order to understand whether CDC25B can activate MPF, we detected the MPF activity and phosphorylation status of CDC2A-Tyr15. At 4 h after mRNA microinjection, as mentioned above, five fertilized eggs cultured in M16 medium were collected at the indicated time points for the assay of MPF activity with H1 as the substrate. In control groups, MPF activity was consistently low at 26-27.5 h, increased initially at
-S229A/S321A, Cdc25b-S321A, Cdc25b-S229A, or Cdc25b-WT was microinjected into each mouse fertilized egg. Eggs were either not microinjected or were microinjected with TE buffer as a control group. Eggs were cultured for 4 h in the absence of dbcAMP in M16 medium, and then immunoblotting was performed for expression of CDC25B using anti-CDC25B or anti-ACTB antibodies. A total of 300 fertilized eggs were loaded onto each lane. B 
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28 h, and reached its maximal level at 28.5 h after the hCG injection ( Fig. 2A) . However, MPF activity had a sharp increase at 26.5 h and peaked at 27 h after the hCG injection in Cdc25b-S321A and Cdc25b-S229A/S321A mRNA-injected eggs (Fig. 2, B and C) , compared with the peak of MPF activity, which occurred at 28 h in both Cdc25b-S229A and Cdc25b-WT mRNA-injected eggs (Fig. 2, D and E) . In Cdc25b-S321A and Cdc25b-S229A/S321A mRNA-injected groups, the maximum of MPF activity was higher than that measured in Cdc25b-S229A and Cdc25b-WT mRNA-injected groups. MPF activity peak value in Cdc25b-S321A and Cdc25b-S229A/S321A mRNA-injected eggs appeared at 27 h after the hCG injection, which is about 1 h earlier than in the Cdc25b-S229A and Cdc25b-WT groups and about 1.5 h earlier than the control groups. Meanwhile, we measured the phosphorylation status of CDC2A-Tyr15 in the control and microinjection groups by Western blotting (Fig. 2F) . In control groups, there was strong inhibitory phosphorylation of CDC2A-Tyr15 at 26.5-27.5 h, a reduced phosphorylation level at 28 h, and no signal at 28.5 h after the hCG injection. In the Cdc25b-S321A and Cdc25b-S229A/S321A groups, there was a weak signal of CDC2A-Tyr15 phosphorylation detected at 26.5 h and no signal found 27-28.5 h after the hCG injection. Conversely, the inhibitory phosphorylation of CDC2A-Tyr15 was observed at 26.5-27 h in the Cdc25b-WT and Cdc25b-S229A groups. These results in each group were coincident with the MPF activity. These data suggest that CDC25B-S321A and CDC25B-S229A/S321A can activate MPF prior to CDC25B-S229A or CDC25B-WT by directly affecting the phosphorylation of CDC2A-Tyr15 in mouse fertilized eggs.
Mouse Fertilized Eggs Microinjected with Either
Cdc25b-S321A or Cdc25b-S229A/S321A mRNA Overcome G 2 Arrest Induced by dbcAMP It has been well documented that cAMP and its analogs, such as dbcAMP, which can activate PRKACA, play a role in regulation of meiosis arrest in mouse oocytes [29, 30] . To directly test whether PRKACA can affect the mitotic cell cycle, mouse one-cell-stage embryos (G 2 phase, 26 h after the hCG injection) were incubated in M16 medium containing various concentrations of dbcAMP. With the increasing concentrations of dbcAMP, we found that 2 mmol/l dbcAMP led to maximal G 2 arrest, and none of the mouse eggs were able to enter M phase of mitosis, suggesting the inhibition of G 2 /M transition (Fig. 3A) . To further explore whether PRKACA could phosphorylate CDC25B on Ser321 or Ser229, we microinjected the mRNA of Cdc25b-S321A, Cdc25b-S229A/S321A, Cdc25b-S229A, or Cdc25b-WT into mouse fertilized eggs (G 2 phase, 26 h after the hCG injection), which were pretreated with 2 mmol/l dbcAMP for about 1 h. Figure 3B showed that   FIG. 2 . Effects of Cdc25b mRNA microinjection on MPF activity and CDC2A-Tyr15 phosphorylation. Five mouse fertilized eggs collected at different time points were assayed for MPF activity using histone H1 as a substrate in control groups (A), Cdc25b-S229A/S321A mRNA injection group (B), Cdc25b-S321A mRNA injection group (C), Cdc25b-S229A mRNA injection group (D), and Cdc25b-WT mRNA injection group (E). For each point, eggs were lysed and MPF activity was examined by scintillation counting and autoradiography. Each value was expressed as mean 6 SD from three independent experiments. F) Western blot analysis of phosphorylation status of CDC2A-Tyr15. The eggs were collected at 26.5, 27, 27.5, 28, and 28.5 h after the hCG injection in all of the examined groups. A total of 200 eggs were loaded onto each lane.
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all of the microinjected Cdc25b mRNAs were translated efficiently in mouse fertilized eggs in the presence of dbcAMP. In control groups, a high number of fertilized eggs arrested at the one-cell stage 29 h after the hCG injection, and almost no eggs reached the two-cell stage 5 h later (34 h after the hCG injection; Fig. 3C ). Despite being cultured in the presence of dbcAMP, eggs injected with mRNA of either Cdc25b-S321A or Cdc25b-S229A/S321A resumed mitosis 30 h after the hCG injection, and more than 90% of eggs developed to the two-cell stage 34 h after the hCG injection (P , 0.001 vs. other groups). However, no eggs injected with Cdc25b-S229A mRNA or Cdc25b-WT mRNA reached the two-cell stage 34 h after the hCG injection, suggesting neither exogenous Cdc25b-S229A nor Cdc25b-WT was sufficient to promote the onset of mitosis. Overall, these data suggest that microinjection of either Cdc25b-S321A mRNA or Cdc25b-S229A/S321A mRNA can effectively override the G 2 phase arrest induced by dbcAMP.
Overexpression of Either CDC25B-S321A or CDC25B-S229A/S321A Can Activate MPF in the Presence of dbcAMP To extend the above observation, the MPF activity after microinjection of Cdc25b-WT mRNA or all of the Cdc25b mutant mRNAs was assessed in mouse fertilized eggs in the presence of dbcAMP. As anticipated, MPF activity remained at a relatively low level at 29-33 h after the hCG injection in both control groups, suggesting that PRKACA activation is responsible for the inhibition of MPF activity (Fig. 4A) . MPF activity fluctuated during the cell cycle, being low at 29 h, increasing initially at 29.5 h, and peaking at 30.5 h after the hCG injection in Cdc25b-S321A and Cdc25b-S229A/S321A mRNA-injected eggs (Fig. 4, B and C) . Cdc25b-S229A and Cdc25b-WT mRNA-injected eggs had low levels of MPF activity in a manner similar to the control groups (Fig. 4, D and  E) . Simultaneously, we detected the phosphorylation status of CDC2A-Tyr15 in all of the examined groups (Fig. 4F) . In control groups, inhibitory phosphorylation of CDC2A-Tyr15 was observed at 29-31 h after the hCG injection. Similar results were observed in Cdc25b-S229A and Cdc25b-WT mRNA-injected groups, indicating that overexpresion of neither CDC25B-S229A nor CDC25B-WT can dephosphorylate CDC2A-Tyr15 in the presence of dbcAMP. On the contrary, strong CDC2A-Tyr15 phosphorylation was found only at 29 h after the hCG injection in Cdc25b-S321A and Cdc25b-S229A/S321A mRNA-injected eggs. The results were consistent with the MPF activity. These data suggest that overexpressing either CDC25B-S321A or CDC25B-S229A/ S321A can activate MPF efficiently, and can make mouse fertilized eggs develop to mitosis even in the presence of dbcAMP.
Phosphorylation Status of CDC25B-S321 In Vivo
In order to identify whether Ser321 of CDC25B was phosphorylated in vivo, we examined the phosphorylation status of CDC25B-Ser321 in mouse fertilized eggs using a phospho-specific antibody that primarily recognizes the phosphorylation form of CDC25B-Ser321. As shown in Figure  5A , the phosphorylated band of CDC25B-Ser321 was observed at the G 1 and S phases, whereas no phosphorylated band of CDC25B-Ser321 was observed at the G 2 and M phases. Moreover, we used a goat polyclonal antibody against the CDC25B N-terminal to measure CDC25B expression at different phases in mouse fertilized eggs. We found that endogenous CDC25B is present in either phosphorylated or unphosphorylated form (Fig. 5B) . The CDC25B protein band observed in both G 1 and S phases was slightly shifted in molecular weight from that in G 2 and M phases. The upper bands (M r : 70 3 10 À3 ) corresponded to the phosphorylated form of CDC25B in Figure 5A . The lower bands (M r : 65 3 10 À3 ) corresponded to the unphosphorylated form of CDC25B at the G 2 and M phases. In order to understand whether CDC25B-Ser321 is phosphorylated in the presence of dbcAMP, we incubated eggs at G 2 and M phases in M16 medium with 2 mmol/l dbcAMP for 6 h. As shown in Figure  5C , the phosphorylated CDC25B-Ser321 was detected at the G 2 and M phases after dbcAMP treatment, indicating that activated PRKACA can phosphorylate Ser321 of CDC25B. These results suggest that CDC25B-Ser321 is phosphorylated FIG. 3 . Microinjection of either Cdc25b-S321A or Cdc25b-S229/S321A mRNA induces mitotic resumption in dbcAMP-arrested eggs. A) Mouse fertilized eggs at the G 2 phase were incubated in M16 medium containing different concentrations of dbcAMP, and the cleavage rate was calculated 5 h later (31 h after the hCG injection). B) Mouse fertilized eggs at the G 2 phase were preincubated with dbcAMP for 1 h and then injected with 0.05 ng mRNA encoding Cdc25b-S229A/S321A, Cdc25b-S321A, Cdc25b-S229A, or Cdc25b-WT. Western blot analysis for expression of CDC25B in microinjection groups and control groups is shown. C) The cleavage rate in cultured mouse embryos after various Cdc25b mRNA injections in the presence of 2 mmol/l dbcAMP. The total number of eggs undergoing division is given on top of the bar graph from three independent experiments. at G 1 and S, whereas CDC25B-Ser321 is dephosphorylated at G 2 and M in vivo.
DISCUSSION
The PRKACA signal transduction pathway has been extensively characterized and plays an important role in meiosis and mitosis arrest [31, 32] . In this study, we provide the experimental evidence for an important role of the PRKACA/CDC25B pathway in the regulation of mitotic entry, and we identify that CDC25B serves as a potential downstream substrate for PRKACA in mouse one-cell-stage embryos. Our previous research showed that PRKACA regulates cell cycle progression of mouse fertilized eggs by inhibiting MPF [33] . Others report that MPF activation at the onset of meiosis is conditioned to the reduction in intraoocyte cAMP [34] . These results suggest that PRKACA may regulate MPF activity directly or regulate it indirectly through another intermediate substrate in mitosis or meiosis arrest. Based on the analysis results of the Scansite software, two potential PRKACA phosphorylation sites, including Ser321 and Ser229 of CDC25B, were predicted, and the results indicate that PRKACA may phosphorylate CDC25B primarily on Ser321, and to a lesser extent on Ser229. CDC25Bs, especially CDC25B-S321A and CDC25B-S229A/S321A, when overexpressed in mouse fertilized eggs not only accelerated the mitotic G 2 /M transition but also stimulated an increase in the cleavage rate in the absence of dbcAMP. Moreover, when we mutated Ser321 and Ser229 of CDC25B to a phospho-mimic glutamate (Cdc25b-S321E or Cdc25b-S321E/S229E), they could not increase the cleavage rate, although overexpression of CDC25B-S229E promoted the cell division, and the cleavage rate was up to 74% in the absence of dbcAMP, indicating that phosphorylation of Ser321 plays no role in promoting egg division (Yu, unpublished data) . Thus, we can conclude that Ser321 of CDC25B is the main site involved in the mitosis progression of mouse fertilized eggs.
We also demonstrated that CDC25B is important for mitosis resumption. Incubation with dbcAMP at different doses induced G 2 /M arrest in a dose-dependent manner, which is in agreement with that seen in the hydrozoan Cytaeis uchida [35] . The mitotic arrest in the mouse fertilized eggs induced by dbcAMP was completely reversed by either CDC25B-S321A or CDC25B-S229A/S321A. In contrast, overexpression of neither CDC25B-S229A nor CDC25B-WT could efficiently override the G 2 arrest in the presence of dbcAMP. These observations strongly suggest that Ser321 of CDC25B is the major site of PRKACA phosphorylation in vivo, and the facilitative effects of the phosphatase are attenuated when this residue is phosphorylated.
It has been found previously that CDC25B can activate initially CCNB1/CDC2A, which initiates mitosis through the   FIG. 4 . Microinjection of either Cdc25b-S321A or Cdc25b-S229A/S321A mRNA activates MPF in the presence of dbcAMP. Five mouse fertilized eggs collected at the indicated time points were assayed for MPF activity in control groups (A), Cdc25b-S229A/S321A mRNA injection group (B), Cdc25b-S321A mRNA injection group (C), Cdc25b-S229A mRNA injection group (D), and Cdc25b-WT mRNA injection group (E). For each point, eggs were lysed, and MPF activity was examined by scintillation counting and autoradiography. Each value was expressed as mean 6 SD from three independent experiments. F) Western blotting for detection of the phosphorylation status of CDC2A-Tyr15 was done as described above.
996 activation of CDC25C [36] . In Xenopus egg extracts, inhibition of endogenous PRKACA in interphase hastens the onset of mitosis, whereas stimulation of PRKACA induces interphase arrest by downregulating CDC25 activity and preventing MPF activation [20] . Therefore, it seems conceivable that PRKACA may act as a negative regulator in mitosis processes through inhibition of CDC25B activity. Since CDC25B-S321A and CDC25B-S229A/S321A can efficiently promote mitotic entry, it raises the question of whether or not CDC25B-S321A and CDC25B-S229A/S321A can regulate MPF activation in mouse fertilized eggs. MPF activation obviously occurred in Cdc25b-S229A/S321A and Cdc25b-S321A mRNA-injected eggs prior to that in either Cdc25b-WT or Cdc25b-S229A mRNAinjected eggs by regulating the phosphorylation status of CDC2A-Tyr15 in the absence of dbcAMP. Sustained activation of PRKACA by dbcAMP blocked MPF activation in CDC25B-WT-overexpressed and CDC25B-S229A-overexpressed eggs, whereas MPF was activated in CDC25B-S229A/S321A and CDC25B-S321A overexpression groups. Thus, the mutation of Ser321 on CDC25B is a strong activating mutation, and is required for MPF activation in the G 2 -arrested eggs. Interestingly, H1-kinase activity began to decrease, despite the fact that the Tyr15 of CDC2A remained dephosphorylated after H1-kinase activity reached its maximal value (Figs. 2 and 4, respectively) . During the cell cycle of frog eggs, CCNB1 accumulates during each interphase and is degraded at the end of each mitosis [37, 38] . So, the MPF activity drop is more likely associated with the CCNB1 degradation. Moreover, we showed that CDC25B-S321 was phosphorylated at the G 1 and S phases, whereas no phosphorylation of CDC25B-S321 was observed at the G 2 and M phases in vivo. But the phosphorylated CDC25B-S321 was detected at the G 2 and M phases in the presence of dbcAMP. These results strongly suggest that PRKACA may inhibit MPF activation by phosphorylating the Ser321 of CDC25B.
Studies in living cells have demonstrated that the regulation of CDC25 function involves the regulated binding of YWHA (also known as 14-3-3) proteins, which act as an adaptor or ''chaperone molecule'' and can bind to signaling proteins, such as serine-phosphorylated RAF1, and regulate maturation of Xenopus laevis oocytes [39] . Previously, YWHA proteins have been identified to interact with CDC25A and CDC25B phosphatases in human cells [40, 41] . Additionally, interaction with YWHA proteins is mediated by phosphorylation of CDC25C at Ser216, thus inhibiting the function of CDC25C [42, 43] . Studies in HeLa cells have demonstrated that Ser323 is a primary YWHA binding site in CDC25B, and this binding blocks the access of the catalytic site, thereby directly inhibiting the activity of CDC25B [44] . But mutation of the Ser323 of CDC25B results in the complete loss of YWHA binding and overcomes the G 2 phase arrest [45] . A similar result has shown that the CDC25 of Xenopus eggs with a point mutation at Ser287 (CDC25-S287A) is incapable of binding to YWHA and thus accelerating mitosis [46] . The Ser321 of mouse CDC25B, which corresponds to the Ser323 of human CDC25B and the Ser287 of Xenopus CDC25, when mutated to a nonphosphorylatable alanine, could completely override the G 2 arrest in our present study. Indeed, we have found that YWHA proteins expressed at various phases in mouse fertilized eggs, and were mainly localized in the cytoplasm and at low levels in the nucleus by Western blotting and immunofluorescence staining, respectively (Yu, unpublished data) . So, we deduce that the Ser321 of CDC25B may bind to YWHA and influence its activity on MPF.
Several reports demonstrate that the complex of CCNB1/ CDC2A is first activated on centrosomes and precedes nuclear mitotic events [47, 48] . It has been shown that CDC25B specifically activates CCNB1/CDC2A on centrosomes, and facilitates the mitosis [49, 50] . Additionally, the translocation of CDC25B from the nucleas to cytoplasm is required for promoting mitosis [51] . These data indicate that CDC25B is a trigger for the mitotic initiation through activating centrosomal MPF in the cytoplasm. In HeLa cells, interaction of CDC25B with YWHA proteins appears to be essential for its cytoplasmic localization [52] . Removal of YWHA proteins, which bind to phosphorylated CDC25 during interphase, is one of the early steps in mitotic activation during the pathway of DNAresponsive checkpoints [53] . Thus, it is possible that the Ser321 of CDC25B is phosphorylated by PRKACA and binds with YWHA in the cytoplasm at the G 1 and S phases, whereas CDC25B performs its initiation of mitosis after the removal of YWHA, thus activating cytoplasmic MPF at the G 2 phase in mouse fertilized eggs. YWHA proteins may be responsible for controlling the timing of CDC25B activation under appropriate conditions and negatively regulate CDC25B.
Taken together, we demonstrate in mouse fertilized eggs that PRKACA plays a critical, regulatory role in cell cycle progression by modulating the activity of CDC25B. These data imply that PRKACA may directly phosphorylate CDC25B on Ser321. In the future, it will be important to show whether PRKACA can indeed phosphorylate CDC25B on Ser321 in vitro and how YWHA proteins regulate CDC25B in the early development of mouse fertilized eggs.
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